Get 40% Off
🤑 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Bausch + Lomb shares climb on earnings beat, raised outlook

Published 01/05/2024, 09:20 pm
© Reuters.
BLK
-

VAUGHAN, Ontario - Bausch + Lomb Corporation (NYSE:BLCO), a global leader in eye health, reported a robust first quarter of 2024, with revenue climbing 18% to $1.099 billion, surpassing the consensus estimate of $1.06 billion.

The company's earnings per share (EPS) matched analyst expectations at $0.07. The positive financial results, coupled with an upgraded revenue outlook for the full year, have driven the company's shares up by 2.5%.

The company's performance was fueled by strong growth across all business segments, with a notable 20% increase in constant currency revenue compared to the first quarter of the previous year.

This growth was achieved despite a $20 million hit from foreign exchange headwinds. Bausch + Lomb's chairman and CEO, Brent Saunders, attributed the success to the company's focus on innovation and the strong performance of its key franchises.

In light of the first-quarter results, Bausch + Lomb has raised its full-year 2024 constant currency revenue growth guidance from 12-14% to 13-15%. The company now anticipates full-year revenue to be between $4.600 billion and $4.700 billion, with adjusted EBITDA (non-GAAP) expected to range from $840 million to $890 million.

The updated guidance reflects an increased foreign exchange revenue headwind, now estimated at approximately $90 million for the year.

Saunders expressed confidence in the company's trajectory, stating, "Our key franchises continue to deliver, and a focus on returning to our roots by prioritizing innovation is producing tangible results."

The company's broad-based growth is supported by the strong uptake of products such as MIEBO® and the XIIDRA® relaunch strategy, which are expected to be bolstered by the upcoming launch of Blink™ NutriTears®.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Investors have responded positively to the earnings report and the company's optimistic outlook, as reflected in the 2.5% rise in the stock price following the announcement. The market's reaction underscores the confidence in Bausch + Lomb's strategic direction and its ability to navigate currency challenges while still delivering growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.